Key facts
| Price (PPV) | 20,057 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | cladribine |
| Class | Immunosuppressants |
| ATC code | L04AA40 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boite de 1 |
| Hospital price | 19,671 MAD |
| Data collected on | 9/8/2026 |
Indications
Mavenclad est indiqué chez les adultes dans le traitement des formes très actives de sclérose en plaques (SEP) récurrente-rémittente, définies par des paramètres cliniques ou l'imagerie.
Find an open pharmacy
On-call pharmacies near you
About Mavenclad 10 mg
Mavenclad 10 mg belongs to the immunosuppressants therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Mavenclad 10 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Mavenclad 10 mg
Answers to common questions from Moroccan patients about this drug.